Abstract

Background Mesenchymal stem cells (MSCs) have the potential to be a source for cell-based therapies. However, MSCs can undergo malignant transformation in the tumour microenvironment where a high level of IL-6 is present. In this study, we investigated the role of IL-6 and STAT3 signalling in malignant transformation of MSCs. Methods Rat MSCs were isolated and indirectly co-cultured with C6 glioma cells. Co-culture of MSCs with astrocytes was used as a control. After 7 days of culture, the cells were assessed for malignant transformation using MTT immunofluorescence staining. The levels of hepatocyte growth factor, IL-6, and basic fibroblast growth factor, and the expression of STAT3 and soluble IL-6 receptor (sIL-6R), in the cultured cells and the conditioned media were measured using RT-PCR, ELISA, and western blotting. The expression levels of STAT3 downstream targets, cyclin D1 and Bcl-xl, were determined as well. Findings Our data show that almost all of the MSCs became phenotypically malignant after indirect co-culture with glioma cells, which was confirmed by tumour formation assays when these cells were injected into nude mice. The expression of IL-6 was significantly increased in the MSCs co-cultured with glioma cells, which was associated with significantly increased expressions of sIL-6R, GP130, STAT3, phosphorylated STAT3, cyclin D1, and Bcl-xl. Similar results were obtained when the MSCs were treated with IL-6. Furthermore, by treating the co-cultured MSCs with glioma by STA-21 to block the constitutive STAT3 signalling, the risk of MSCs tumour-like transformation in the tumour microenvironment was reduced. Interpretation These data suggest that IL-6 plays a critical role in the malignant transformation of rat MSCs, which is associated with an enhancement of the STAT3 signalling pathway in the tumour microenvironment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call